Evidence map›Paper›PMID 34616024›Full record

ArticleNature cell biology2021

Cargo-specific recruitment in clathrin- and dynamin-independent endocytosis.

Paulina Moreno-Layseca, Niklas Z Jäntti, Rashmi Godbole, Christian Sommer, Guillaume Jacquemet, Hussein Al-Akhrass, James R W Conway, Pauliina Kronqvist, Roosa E Kallionpää, Leticia Oliveira-Ferrer and 12 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature cell biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Spatial N-glycan rearrangement on αNature communications · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Rab21 recruits EEA1 and competes with Rab5 for Rabex-5 activation.Frontiers in cell and developmental biology · 2025
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 5 countries.

Paulina Moreno-LaysecaTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.ORCID http://orcid.org/0000-0002-9456-4178
Niklas Z JänttiTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.ORCID http://orcid.org/0000-0003-1547-0390
Rashmi GodboleNational Centre for Biological Science (TIFR), Bangalore, India.
Christian SommerMax-Delbrück-Centrum für Molekulare Medizin (MDC), Berlin, Germany.
Guillaume JacquemetTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.ORCID http://orcid.org/0000-0002-9286-920X
Hussein Al-AkhrassTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.ORCID http://orcid.org/0000-0002-9630-3000
James R W ConwayTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.ORCID http://orcid.org/0000-0003-3787-277X
Pauliina KronqvistInstitute of Biomedicine, Faculty of Medicine, University of Turku, Turku, Finland.
Roosa E KallionpääAuria Biobank, Turku University Hospital and University of Turku, Turku, Finland.ORCID http://orcid.org/0000-0003-0146-0060
Leticia Oliveira-FerrerUniversity Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
Pasquale CerveroUniversity Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.ORCID http://orcid.org/0000-0002-9417-7733
Stefan LinderUniversity Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.ORCID http://orcid.org/0000-0001-8226-2802
Martin AepfelbacherUniversity Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
Henrik ZauberMax-Delbrück-Centrum für Molekulare Medizin (MDC), Berlin, Germany.
James RaeInstitute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.
Robert G PartonInstitute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0002-7494-5248
Andrea DisanzaIFOM, Fondazione Istituto FIRC di Oncologia Molecolare and University of Milan, Milan, Italy.ORCID http://orcid.org/0000-0001-5101-2907
Giorgio ScitaIFOM, Fondazione Istituto FIRC di Oncologia Molecolare and University of Milan, Milan, Italy.ORCID http://orcid.org/0000-0001-7984-1889
Satyajit MayorNational Centre for Biological Science (TIFR), Bangalore, India.
Matthias SelbachMax-Delbrück-Centrum für Molekulare Medizin (MDC), Berlin, Germany.ORCID http://orcid.org/0000-0003-2454-8751
Stefan VeltelUniversity Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany. Stefan.Veltel@hs-bremen.de.ORCID http://orcid.org/0000-0002-4925-3776
Johanna IvaskaTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland. Johanna.Ivaska@utu.fi.ORCID http://orcid.org/0000-0002-6295-6556
Åbo Akademi University · FIUniversität Hamburg · DEMax Delbrück Center · DENational Centre for Biological Sciences · INThe University of Queensland · AUUniversity of Milan · ITUniversity of Turku · FI

Funding

DBT-Wellcome Trust India Alliance IA/M/15/1/502018
6 · The paper itself

Abstract

Spatially controlled, cargo-specific endocytosis is essential for development, tissue homeostasis and cancer invasion. Unlike cargo-specific clathrin-mediated endocytosis, the clathrin- and dynamin-independent endocytic pathway (CLIC-GEEC, CG pathway) is considered a bulk internalization route for the fluid phase, glycosylated membrane proteins and lipids. While the core molecular players of CG-endocytosis have been recently defined, evidence of cargo-specific adaptors or selective uptake of proteins for the pathway are lacking. Here we identify the actin-binding protein Swiprosin-1 (Swip1, EFHD2) as a cargo-specific adaptor for CG-endocytosis. Swip1 couples active Rab21-associated integrins with key components of the CG-endocytic machinery-Arf1, IRSp53 and actin-and is critical for integrin endocytosis. Through this function, Swip1 supports integrin-dependent cancer-cell migration and invasion, and is a negative prognostic marker in breast cancer. Our results demonstrate a previously unknown cargo selectivity for the CG pathway and a role for specific adaptors in recruitment into this endocytic route.

Indexed as

EndocytosisActinsBiological TransportBreast NeoplasmsCell MovementClathrinDynaminsFemaleHumansIntegrin beta1Intracellular Signaling Peptides and Proteinsrab GTP-Binding ProteinsActinsClathrinDynaminsIntegrin beta1Intracellular Signaling Peptides and ProteinsRAB21 protein, humanrab GTP-Binding ProteinsWSB1 protein, human

Identifiers

PMID34616024
PMCPMC7617174
OpenAlexW3204450518

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.